"We can do better," commissioner says ...

FDA officials want more AI in the review process. The Food and Drug Administration (FDA) is looking to AI to solve the problem of lengthy approval processes, as the Trump administration invests in ...

Each year, the FDA approves a wide range of medications that help shape the future of medicine in the U.S. These include novel drugs that offer new treatment options, as well as first generics and ...

WASHINGTON (7News) — Artificial intelligence is poised to dramatically reshape the process of developing and approving new medicines, according to industry experts. Traditionally, the path from drug ...

The FDA has granted priority review status for pegcetacoplan (Empaveli) to treat two rare kidney diseases that can lead to kidney failure. Up until now, there hadn’t been any drugs approved ...

Accelerated approval of semaglutide 7.2 mg establishes a higher-dose, once-weekly GLP-1 RA option for long-term weight ...

FDA drug approval costs have increased significantly over the past ten years, skyrocketing from roughly $30 million per medication in 2015 to more than $50 million in 2025. -- This only includes ...

Is CMS Circumventing FDA Drug Approval Standards While Congress Moves to Shut the Hemp Market Down? With Congress tightening ...

The State of Texas will launch its own program to research a psychoactive drug called ibogaine after it was unable to find a ...